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ABSTRACT 
 
Background: Phthalates are highly used chemical additives, plasticizers, and solvents 
found in a wide range of consumer products from auto parts and toys to personal care 
products and foods. Being so ubiquitous in our daily environments, phthalates have been 
studied to evaluate their potential for adverse affects on animals, and were found to cause 
anti-androgenic affects in rats, low birth weight, shortened gestational period as well as 
birth defects. Newer studies are beginning to look at these factors as they relate to 
humans. This systematic review used GRADE to evaluate the quality of evidence in the 
most recent studies on newborn birth outcomes that were exposed prenatally to 
phthalates.  
 
Methods: A systematic review of studies written between 2000 and 2010, using published 
literature in the English-language, was conducted using MEDLINE, Evidence-Based 
Medicine Reviews Multifile, and Web of Science using keywords phthalate, phthalates, 
prenatal, anogenital distance, AGD, birth, low birth weight and birth outcomes. Articles 
that examined the birth outcomes of birth weight, birth length, head circumference and 
gestational age after in utero exposure to phthalates were selected. Four studies were 
analyzed for result outcomes. 
 
Results: Three of the four studies have demonstrated that in utero exposure to 
environmental phthalates is associated with either newborn birth weight, birth length, 
head circumference or gestational age. The forth study reported no significant 
relationships between prenatal exposure to phthalates and any of the birth outcomes.  
 
Conclusion: The findings deduced in this study using the GRADE process, suggest that, 
at the current level of exposure, phthalates may have subtle affects on the fetus in relation 
to certain birth outcomes. However, the evidence is of low quality and further 
investigation is needed to truly report that these findings are not due to other limitations 
such as other environmental chemicals not evaluated or confounding factors such as self-
reported values. 
 
Keywords: phthalate, phthalates, prenatal, anogenital distance, AGD, birth, low birth 
weight and birth outcomes 
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INTRODUCTION 
Background 
Phthalates are chemical additives that act as fixatives and solvents, and are widely 
used in consumer products to carry fragrances and soften plastics. They are found in a 
wide range of vinyl plastic products from toys to medical equipment. However, they are 
also found in personal care products and foods, including infant formula and baby food 
(Stillerman, Mattison, Giudice, & Woodruff, 2008). Phthalates have been found to be 
ubiquitous in our daily environments (Zhang et al., 2009). They are volatile in nature and 
leach out of products, at measurable rates, into the surrounding environment. Varying 
levels of exposure are present in everyone on a daily basis dependent on fluctuating 
degrees of exposure and the body’s ability to metabolize these chemicals, which is 
relatively quickly, from a few hours or within days (Huang, Kuo, Chou, Lin, & Lee, 
2009; Zhang et al., 2009).  
To date, phthalates have been studied for a verity of outcomes on animals and 
humans, and there has been developing concern that phthalates pose harm to humans in a 
number of ways. One particular concern is the potential harm to the fetus. Increased 
understanding shows that there are sensitive windows of development to the individual 
fetal biologic systems, such as – cardiovascular, respiratory, endocrine and even general 
growth (Stillerman et al., 2008), that, if even exposed to subtle amounts of chemicals, 
may alter the function and morphology of that fetus (Suzuki et al., 2010). One study 
mentioned, “Changes in birth weight or early body weight in rodents after prenatal 
exposure to various phthalates have been reported (Sharpe et al. 1995; Tanaka 2002, 
2003, 2005), but reports of no effects also exist (Arcadi et al. 1998; Hoshino et al. 2005)” 
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(Wolff et al., 2008, p. 1092). Of concern here are the effects phthalates may have on birth 
outcomes, for example as with “birth weight and length of gestation, [as these] are 
important predictors of neonate and infant health” (Stillerman et al., 2008, p. 632). “Low 
birth weight (LBW) is one of the leading causes of mortality in children under age 5 
years and is associated with increased risk of cardiovascular and metabolic disease in 
adulthood 1-3” (Zhang et al., 2009, p. 500).  In addition, low birth weight infants “… also 
experience significantly higher rates of morbidity during the perinatal period than term 
and normal birth weight infants” (Stillerman et al., 2008, p. 632). Studies have thus been 
looking at how these chemicals affect humans to answer the questions that remain 
concerning the overall effect that phthalates pose on these and other human biologic 
systems before and after birth. 
 
Purpose of the Study 
The purpose of this paper is to conduct a systematic review of the literature to 
determine the teratogenic effects of in utero fetal exposure to phthalates and birth 
outcomes broken down into four groups – birth weight, birth length, head circumference, 
and gestational age. This was accomplished using the “GRADE” stepwise approach to 
evaluating studies and their outcomes.  
 
 
METHOD 
 
An extensive literature search was performed using MEDLINE, Evidence-Based 
Medicine Reviews Multifile, and Web of Science. All databases were accessed through 
the Pacific University Library System. The key words searched included phthalate, 
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phthalates, prenatal, anogenital distance, AGD, birth, low birth weight and birth 
outcomes, individually and in combination. The search was limited to human subjects, 
the English language, and studies completed between 2000 and 2010. Once combined, 
this resulted in nine studies to review from Medline, 10 from Evidence-Based Medicine 
Reviews Multifile, and 20 from Web of Science. Further review of these articles was 
needed to verify study purposes and outcomes, and to extract duplicated references, 
animal studies, or letters to the editor. Four articles were acquired and set for review.  
Exclusion criteria included articles with animals and articles that focused more on 
potential behavioral affects of phthalates on children. Letters to the editor, descriptive 
studies and articles without full text accessibility were excluded. Only cohort and case-
control studies were identified, as performing randomized trials of this nature would be 
unethical. 
Between 2008 and 2010 four studies were published that met the criteria for 
evaluating the risk to the fetus of exposure to phthalates. The types of phthalates 
evaluated and their metabolites were reported in all studies. The newborns birth weight, 
birth length, and gestational age were reported by all studies, but head circumference was 
only measured and reported by two of the studies. Maternal urine samples were used by 
the three cohort studies, to evaluate phthalate exposure levels, where as the case-control 
study used maternal blood, umbilical vein blood and neonate meconium samples for 
phthalate or phthalate metabolite levels. Amniocenteses were performed on all subjects 
prior to giving birth only in one cohort study. Maternal demographics, anthropometrics, 
number of pregnancies and social-economic factors were taken and considered by all 
studies, but only three provided the data in their reports. Newborns were otherwise heal-
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thy in all studies. The sample size ultimately ranged between 65 mother-infant pairs to 
352 after adjusting for incomplete data on participants and those lost to follow up for 
various reasons. Studies were either cohorts (3) or case-controls (1). 
 
 RESULTS 
 
 Of the four studies included in this systematic review, three were cohort studies 
and one was a case control study that studied the birth outcomes of newborns that were 
exposed in utero to phthalates.  
 The Huang et al. (2009) study, is a cohort study that took place during 2005-2006, 
in Taiwan. They started with 83 participants who had planned to undergo amniocentesis 
due to indications of “advanced age” or “abnormal maternal serum screening (alpha fetal 
protein and β-hCG)”, and complete information on 65 of the participants was reported. 
No explanation was given for the 18 lost at this point. All participants and their fetuses 
were diagnosed healthy after chromosome evaluation of the amniotic fluid. Due to 
significant differences between the males and females in birth weight, length and 
gestational age, they grouped the newborns according to gender for statistical analysis.  
 The analysis of the amniotic fluid in Huang et al. (2009) found that the fetuses 
were overall exposed to di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate 
(DEHP) as the metabolite detectable rates found in the fluid were 100% for monobutyl 
phthalate (MBP) and >90% for mono-2-ethylhexyl phthalate (MEHP). Trace amounts of 
other phthalates were found and not reported. One sample failed during this analysis.  
 The maternal urinary analysis measured five metabolites MBP, MEHP, 
monoethyl phthalate (MEP), mono methyl phthalate (MMP), and mono benzyl phthalate 
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(MBzP) with the highest concentrations being for the first three at 100%, 98%, 96%, 
respectively. They report that fetal exposure during “early pregnancy” was to DBP, 
DEHP and DEP. Compared together there was “…a significant positive correlation only 
between urinary MBP and amniotic MBP in all newborns (R2 = 0.156, p = 0.002)” 
(Huang et al., 2009, p.16). 
 Of the male newborns in the study, there were no significant differences found in 
exposures to phthalates in any category. For the female newborns, those categorized to 
the high-level MBP-AF (monobutyl phthalate-amniotic fluid) had significantly higher (p 
= 0.031) birth weights and lengths as compared to the low-level MBP-AF group (p = 
0.018). In this study, high and low-level MBP-AF refers to higher or lower 
concentrations of phthalates in amniotic fluid. Of these same groups, they go on to 
discuss the differences found in anogenital distances (AGD’s) that were found to be 
shorter in the high-level MBP-AF group, with the larger birth weights and lengths, as 
compared to the low-level MBP-AF group (13.9mm vs 17.6mm, p = 0.024). Then, to 
adjust for differences in weight and length an anogenital index (AGI) was calculated for 
each. Of the two values obtained, the smaller value was linked to the high-level MBP-AF 
group. The values being 4.5mm/kg to 6.2mm/kg, p < 0.01 for the AGI-Ws and 2.8 to 3.7 
for AGI-L, p < 0.01. This significance was also found in the MEHP-AF groups, high and 
low-level values of 4.7mm/kg to 6.0mm/kg in the AGI-Ws, p < 0.05 and 2.8 to 3.6 for 
AGI-L, p < 0.05. The authors concluded that they found a significantly negative 
correlation between amniotic fluid MBP and AGD and AGI-W.  
 The second study reviewed was conducted by Suzuki et al. (2010), who 
specifically looked for nine different phthalate ester metabolites in the urine of 149 
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healthy pregnant Japanese women living in Tokyo, Japan during 2005-2008, and 
evaluated their newborns’ birth outcomes for variations. Of the nine metabolites looked 
at, MMP, MEP, mono-n-butyl phthalate (MnBP), MBzP, MEHP, mono-2-ethyl-5-
hydroxyhexyl phthalate (MEHHP), mono-2-ethyl-5-oxyhexyl phthalate (MEOHP), 
mono-iso-nonyl phthalate (MINP) and mono-n-octyl phthalate (MnOP)  they found no 
statistically significant correlation between the metabolites and birth outcomes for the 
individual phthalate ester metabolites or when they were lumped into high and low- 
molecular weight phthalate (MWP) sum groups.  
 The third study reviewed, Wolff et al. (2008), was an American cohort study that 
began with 382 young, healthy, “largely nonwhite,” mother-infant pairs, in New York 
City from 1998 to 2002. The final sample size was 352 – 190 Hispanic, 107 Black, 80 
White and 5 Other. Their research pertained to third trimester phthalate exposures. Urine 
levels of phthalate biomarkers were found on ten different metabolites those being mono-
2-ethyl-5-carboxypentyl phthalate (MECPP), MEHHP, MEOHP, MEHP, MBzP, mono-
3-carboxypropyl phthalate (MCPP), monoisobutyl (MiBP), MBP, MEP and MMP. From 
these ten phthalate metabolites, three groups were formed, to analyze the micromolar 
sums (µmol/L), two were according to the molecular weight of the individual metabolites 
– low-MWP (MiBP, MBP, MEP, MMP) and high-MWP (MECPP, MEHHP, MEOHP, 
MEHP, MBzP, MCPP), the other group – DEHP-MWP (MECPP, MEHHP, MEOHP, 
MEHP) because these four metabolite all originate from DEHP. They found no 
significant association of the latter two groups for any birth outcome, whereas, the “low- 
MWP metabolites were positively associated with head circumference (β = 0.13 cm; 95% 
CI, 0.01-0.24cm) and gestational age (β = 0.14 week; 95% CI, 0.01-0.27week).” The 
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tertiles of the low-MWP metabolites on head circumference were not significantly 
associated with phthalate exposure, (no data provided). Whereas, the second and third 
tertiles on gestational age for “low-MWP metabolites predicted 0.4 week longer gestation 
compared with the first tertile (adjusted predicted means: third tertile, 39.6 weeks; 95% 
CI, 39.1-40.1 weeks; second tertile, 39.7 weeks; 95% CI, 39.2-40.2 weeks; first tertile, 
39.2 weeks; 95% CI, 38.7-39.6 weeks)” (Wolff et al., 2008, p. 1095). 
Lastly, Zhang et al. (2009), is a case-control study that evaluated 201 Chinese 
mother-infant pairs living in Shanghai, China during 2005-2006. Eighty-eight low birth 
weight (LBW < 2,500g) term (>37weeks) newborn cases and 113 normal birth weight 
term newborn controls (birth weight ≥ 2,500g) were compared. They used maternal and 
cord blood along with newborn meconium samples to evaluate types and amounts of 
phthalate exposure to DEP, DBP, and DEHP and two monoester metabolites derived 
from these three, MBP and MEHP.  
Initially, Zhang et al. (2009) reported that the LBW cases had higher levels of 
phthalates and monoesters as compared to the controls. The significant odds ratios (OR) 
and confidence intervals (CI) were found and maternal blood DBP results were 2.2 (1.4 – 
3.2) for the control group, and 2.9 (2.5 – 3.4) for LBW cases with p = .02; for maternal 
blood MEHP 1.4 (1.2 – 2.1) for the control, and 2.9 (1.8 – 3.5) for LBW cases with p = 
.000. In cord blood the OR and CI were reported for DBP as 1.8 (1.2 – 2.7) for control, 
and 2.7 (2.2 – 3.0) for LBW cases p = .002, and for cord blood MEHP values of 1.1 (0.9 
– 1.7) for control and 2.5 (1.6 – 3.4) for LBW cases with p = .000. In neonate meconium 
the values for MBP were 1.7 (1.2 – 2.4) for the control group, and 2.2 (1.6 – 3.6) in the 
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LBW cases, with p = .003, and neonate meconium MEHP values were 2.9 (1.8 – 4.4) for 
the control, and 5.5 (3.4 – 9.3) for the LBW cases, with p = .000, (Zhang et al., 2009).  
Secondly, using Spearman correlations, they found that LBW was significantly 
associated with in utero exposure to DBP in cord blood, correlation coefficient of -0.23 
with p = 0.01, and in meconium -0.56 with p = 0.000. Shorter birth length was associated 
with cord blood DEHP exposure with values of -0.22 with p = 0.05, and meconium 
MEHP values of -0.47 with p = 0.000. 
Lastly, dose-response relationships were found, and an increased risk of LBW 
was linked to the highest quartiles of DBP and DEHP concentrations. They reported the 
OR and CI’s of 3.54 (1.54-6.15) p = 0.008 and 2.05 (1.17-3.70) p = 0.05, respectively. 
Again dose-response relationships were found between the MEHP in its highest quartile 
of meconium level and LBW, 3.23 (1.31 – 5.94) p = 0.04.  “For DBP, a dose-response 
relationship was found between LBW and both DBP level in cord blood and MBP level 
in meconium” (Zhang et al., 2009, p. 502). As for DEP and DEHP, differences were not 
observed between LBW infants and controls.  
 
DISCUSSION  
 Phthalates are commonly used chemicals in our society, and thus exposure to 
these pollutants occurs nearly every day. Concerns for potential human structural 
alterations (birth defects) related to in utero exposure to phthalates have developed from 
many animal studies that have found issues affecting development, thus the question here 
is how do these chemicals affect humans in this critical time of development in relation to 
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birth weight, birth length, head circumference and gestational age. The four studies 
reviewed were evaluated using GRADE to rate the quality of evidence.  
The first graded outcome was birth weight, as all studies reported on this finding. 
Interestingly enough, the reported GRADE findings were mixed between association and 
no association of phthalates and birth weight. Firstly, this groups study quality was 
decreased due to negligence in reporting 18 subjects information and why they were lost 
to follow-up, as well as not reporting the maternal demographics (i.e. age, number of 
pregnancies, anthropometrics, social habits and socio-economic factors) by (Huang et al., 
2009). To go along with study quality, only Zhang et al. (2009) reported any blinding of 
any kind. Thus, this lack of reporting decreased the grade in study quality for BW 
outcomes.  
Due to variability in the reported results for BW outcomes, the area of consistency 
was dock a point. Of the 3 phthalates and the 13 phthalate metabolites measured between 
all studies, only one particular phthalate was related in both studies that found 
associations to BW, di-n-butyl phthalate (DBP) and its metabolite monobutyl phthalate 
(MBP). Of these findings, that associated phthalates with BW, there was opposite affects 
reported, one being for an increased birth weight associated with MBP only in female 
newborns and the other found an association between low birth weight (LBW) and DBP. 
These were Huang et al. (2009) and Zhang et al. (2009), respectively.  The other two 
cohorts, Suzuki et al. (2010) and Wolff et al. (2008), both reported no association 
between BW and any of the nine or ten, respective, phthalate ester metabolites measured. 
One last concern for study quality lies in the fact that the case-control by Zhang et al. 
(2009) was the only study to not use urine samples to evaluate phthalates, instead they 
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used maternal blood, umbilical vein blood and neonate meconium. This is not to say they 
are wrong by doing so, but in matters of being evaluated on the same level as the other 
studies this had to be taken into account for determining the grade. Down grading the 
studies for the above stated lack of consistencies was deemed appropriate.  
Precision was questioned for BW, as all studies reported their levels of 
significance in various statistical forms, and confidence intervals (CI) were not given in 
all studies, making it difficult to verify their precision. Size of the study populations were 
also regarded for precision and found that the smallest cohort, Huang et al. (2009) and the 
case-control, Zhang et al. (2009), had the most significant findings in regards to BW. The 
two largest cohorts, Suzuki et al. (2010) and Wolff et al. (2008), found no association to 
BW.  
The directness and publication bias were left the same, as all studies appear to not 
impede on these qualities.  
However, Zhang et al. (2009) reported a dose-response in their case-control 
between levels of DBP, MBP, MEHP and LBW. This was noted along with the well 
discussed confounders and limitations and points were added to each category.  
The evidence for BW started and ended with a Low rating after all was taken into 
account.  
 The second graded outcome was birth length (BL). This category comprised all 
four studies being reviewed as well, and here the findings were found to be mixed 
between association and no association of phthalates and BL.  
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In the area of study quality for BL, due to factors of unreported reasons for loss to 
follow-up, lack of maternal demographic data reporting and lack of blinding this category 
was marked down for the lack of detail, as mentioned above in more detail under BW. 
 As for consistency for BL outcomes, a deduction was made for the variations in 
the split associations between increased and decreased BL, and two no associations. MBP 
was reported to cause an increased BL in female newborns only and DEHP actually 
caused decreases in BL as per Huang et al. (2009) and Zhang et al. (2009) respectively.  
Wolff et al. (2008) actually showed one individual value for monobenzyl phthalate 
(MBzP) as being significant to BL on its own, but when placed in its high-molecular 
weight phthalate (high-MWP) group to figure the sum it lost significance and so along 
with Suzuki et al. (2010) they declared no association between phthalate metabolites and 
BL. All other categories for the GRADE table, under BL, were unchanged. These 
weaknesses brought the starting grade for BL down from Low to Very Low.  
Head circumference (HC) was the third graded outcome and only involved two 
cohort studies Suzuki et al. (2010) and Wolff et al. (2008). All categories to decrease the 
grade were unchanged as these studies showed no need to lower the grade although, 
variation in consistency was questioned as Wolff et al. (2008) noted an association in the 
low-molecular weight phthalate (low-MWP) group and HC where Suzuki et al. (2010) 
found no association. However, in Wolff et al. (2008), their tertile for the low-MWP 
group found no significance. As for increasing the HC grade, sufficient delineation of the 
possible confounders associated with HC ultimately marked up this groups starting grade 
from Low to Moderate evidence.  
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The fourth and final graded outcome, gestational age (GA), involved all three 
cohorts, of which only one, Wolff et al., found an association between GA and 
phthalates. The study quality was marked down for the lack of reporting of the loss to 
follow-up reasons and maternal demographic information as mentioned before in Huang 
et al. (2009). In addition, since Wolff et al. (2008) found a small increase in GA in 
relation to the low-MWP group, the consistency varied between association and no 
association, and thus gave more strength in decreasing this category. However, the 
discussion on GA confounders was very in depth and was explained well especially by 
Wolff et al. (2008) who found the association. They explain that these findings may 
“…reflect unresolved confounding…” (Wolff et al., 2008, p. 1095) due to correlations 
found between low-MWP and BMI, BMI and GA, and between low-MWP and 
creatinine, and concluded that maternal anthropometrics may affect the low-MWP 
exposure level, the creatinine measurement and the outcome measurement. And due to 
rough self-reported anthropometrics confounding was possible (Wolff et al., 2008). 
Given these factors, the GA group was given an increase in the area of confounders. All 
other categories were unchanged to the GRADE chart, leaving the GA group with a Very 
Low evidence rating.  
Pooling the evidence, on the GRADE chart, from each grouping, the “Low” for 
birth weight, the “Very low” for birth length, the “Moderate” for head circumference and 
the “Very Low” for Gestational Age, altogether, give the overall grade of evidence as 
“Low”. This “Low” rating, suggest that future research will very likely provide better 
confidence in the estimate of association between phthalates and birth outcomes.  
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As these findings of decreased birth weight, length, head circumference or 
gestational age may not initially seem to be a big concern, clinically speaking, studies 
have found that factors such as “low birth weight infants experience longer hospital stays 
at birth and a greatly increased risk of respiratory distress syndrome. Intrauterine growth 
restriction has been identified as a significant risk factor for chronic hypertension, heart 
disease, lung disease, and type 2 diabetes later in life,10 creating the need to understand 
the impact of adverse pregnancy outcome across the life course” (Stillerman et al., 2008, 
p. 632). They go on to strongly mention that “adverse birth outcomes are a financial and 
emotional burden on families both in the short and long term. Average hospital charges 
for premature births in 2003, for example, have been estimated to be $18.1 billion, about 
half the total infant hospital charges for all US births11” (Stillerman et al., 2008, p. 632). 
For this purpose, phthalates should continue to be studied and evaluated to assure quality 
of life from beginning to end. 
For future studies, in relation to phthalates and birth outcomes, other confounders 
and limitations were mentioned by these studies, a few of which that were not previously 
mentioned above are mentionable here. Huang et al. (2009) mentioned that only one 
urinary and amniotic phthalate metabolite (MBP) was found to have a modest correlation, 
where the other metabolites measured showed no significance. They concluded that this 
may possibly be that the non-significant phthalate, DEP, in this case, has a short, 4-hour 
half-life in humans, which lead to decreased levels available to cross from the mother 
into the placenta. Another limitation noted in the studies was the inability to completely 
assess the sources and amounts of exposure for each individual phthalate to each 
pregnant woman, not to mention the list of other known chemicals that can cause changes 
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to birth outcomes for which exposures were not accounted for in these studies (Huang et 
al., 2009; Suzuki et al., 2010; Wolff et al., 2008; Zhang et al., 2009). And though the 
majority of these studies factored in smoking, side stream smoke at home or in the work 
environment was not taken into account but it is definitely a factor that could affect birth 
weight (Zhang et al., 2009). Though there are many factors to take into account, and 
though the evidence presented here was Low for the current level of exposures and there 
outcomes, clinically there is still a need to verify that in utero exposures to phthalates are 
not causing problems to the fetus, and, that may, cause problem later on in life. 
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Mixed – Association 
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Birth 
Length 
3 Cohorts and 
1 Case-control 
Mixed – Association 
and no Association Low -1 -1 0 0 0 0 0 0 Very Low 
Head 
Circumference 2 Cohorts 
Mixed – Association 
and no Association Low 0 0 0 0 0 0 0 1 Moderate 
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Age 3 Cohorts 
Mixed – Association 
and no Association Low -1 -1 0 0 0 0 0 1 Very Low 
  
Table of Phthalates and Phthalate metabolites measured in each study 
 
 
 
 
 
 
 
 
 
 
Huang et al. - Taiwan Zhang et al. - China Suzuki et al. - Japan Wolff et al. - America 
MBP DEP MBzP MBP 
MEHP DBP  MEHHP MBzP 
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